Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.041
Q1
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Journal:
Clin Infect Dis
Publicación independiente
Impact factor
8.313
Q1
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Journal:
Expert Rev Infect Ther
Publicación independiente
Impact factor
3.767
Q1
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Journal:
Clin Therap
Publicación independiente
Impact factor
3.119
Q2
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Journal:
Allergol Immunopathol (Madr)
Publicación independiente
Impact factor
1.276
Q3
Year:
2014
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Journal:
Enferm Infecc Microbiol Clin
Publicación independiente
Impact factor
1.654
Q3
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Jacobo Pardo-Seco, Federico Martinón-Torres and Antonio Salas
Journal:
BMC Genomics
Publicación independiente
Impact factor
3.594
Q2
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Jan De Waele, Jeffrey Lipman, Yasser Sakr, John C Marshall, Philippe Vanhems, Casiano Barrera Groba, Marc Leone, Jean-Louis Vincent and for the EPIC II Investigators
Journal:
BMC Infec Dis
Publicación independiente
Impact factor
2.688
Q3
Year:
2014
Doi:
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study
Thierry Gustot, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S. Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent and for the EPIC II Group of Investigators
Journal:
Liver Internat.
Publicación independiente
Impact factor
5.175
Q1
Year:
2014
Doi:
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Fe de errores de «Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes»
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
A Genome-Wide Study of Modern-Day Tuscans: Revisiting Herodotus’s Theory on the Origin of the Etruscans
Jacobo Pardo-Seco, Alberto Gómez-Carballa, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Immunisation against meningococcus B: the case of Spain
Federico Martinón Torres
Journal:
Lancet
Publicación independiente
Impact factor
60.392
Q1
Read my lips: oral manifestations of systemic diseases.
de Castro López MJ, Illade Quinteiro L, Martinón Torres F, Cutrín Prieto JM.
Journal:
Journal of Pediatrics
Publicación independiente
Impact factor
3.700
Q1
Dr. Google: what about the human papillomavirus vaccine?
Leticia Pías-Peleteiro, Javier Cortés-Bordoy, and Federico Martinón-Torres
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Adaptive support ventilation: State of the art review.
Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.
Journal:
Indian J Crit Care Med
Publicación independiente
Impact factor
Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes
Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin
Journal:
J. Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
No results found.
KAWASAKI DISEASE IN INFANTS 3 MONTHS OF AGE AND YOUNGER: A MULTICENTRE SPANISH STUDY
Grasa CD, Fernandez-Cooke E, Sánchzez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña r, Calvo C, Spanish network for the study of Kawasaki disease. KAWA-RACE (Martinón-Torres F)
Doi:
Ann Rheum Dis
Factor de impacto:
Q1
Doi:
PRIORITY NEEDS FOR CONDUCTING PANDEMIC-RELEVANT CLINICAL RESERACH WITH CHILDREN IN EUROPE: A CONSENSUS STUDY WITH PEDIATRIC CLINICIAN-RESEARCHERS.
Micaela Gal, Nina Gobat, Nicholas A. Francis, Kerenza Hood, Christopher C. Butler, Julia Bielicki, Pieter L. Fraaij, Mike Sharland, Jessica Jarvis, Annemarie M.C. van Rossum, Terho Heikkinen, Federico Martinon-Torres, Jethro Herberg, Angela Watkins, Steve A.R. Webb, Ronnie Moore, Prasanth Sukumar, and Alistair Nichol
Doi:
Pediatric Infect Dis J
Factor de impacto:
Q2
Doi:
DIAGNOSIS OF KAWASAKI DISEASE. USING A MINIMAL WHOLE-BLOOD GENE EXPRESSION SIGNATURE
Victoria J.Wright, Jethro A. Herberg,Myrsini Kaforou, Chisato Shimizu, Hariklia Eleftherohorinou, Hannah Shailes, Anouk M. Barendregt, Stephanie Menikou, Stuart Gormley, Maurice Berk, Long Truong Hoang, Adriana H. Tremoulet,John T. Kanegaye, Lachlan J. M. Coin, Mary P. Glodé, Martin Hibberd, TacoW. Kuijpers, Clive J. Hoggart, Jane C. Burns, Michael Levin, FRCPCH; for the Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric; Emergency Medicine Kawasaki Disease Research Group (PEMKDRG)
Doi:
JAMA
Factor de impacto:
Q1
Doi:
CRITERIA HETEROGENEITY IN THE DIAGNOSIS OF ACUTE BRONCHIOLITIS IN SPAIN
Alfredo Cano-Garcinuño, Manuel Praena-Crespo, Isabel Mora-Gandarilla, Ignacio Carvajal-Urueña, María Teresa Callén-Blecua, Águeda García-Merino, Grupo de Expertos para el Diagnóstico de la Bronquiolitis (Martinon-Torres, F)
Doi:
An Ped
Factor de impacto:
Q3
Doi:
PAEDIATRIC RESEARCH IN SPAIN: CHALLENGES AND PRIORITIES.INVEST-AEP Platform
Cristina Calvo, Talía Sainz, Pilar Codoner-Franch, Begona Santiago,M. Luz García-García, César García Vera, M. Angeles Munoz-Fernandez,Antonio Pérez-Martínez, Irene Rivero, Cristina Fernandez Pérez,Asunción Mejías, Federico Martinón-Torres, Fernando Cabanas, Plataforma INVEST-AEP
Doi:
An Pediatr (Barc)
Factor de impacto:
Q3
Doi:
INMUNOGENICITY AND SAFETY OF MEASLES-MUMP-RUBELLA VACCINE AT TWO POTENCY ADMINISTERED TO HEALTHY CHILDREN AGED 12-15 MONTHS:A PHASE III, RANDOMIZED, NON-INFERIORITY TRIAL
Ahonen, Anitta; Berry, Andrea; Chatterjee,Archana; Clifford, Robert; Diaz Perez, Clemente; Diez-Domingo, Javier; Haney, Byron; Harrison, Christopher J;Kerdpanich, Angkool Phirangkul; Lee, Jimmy KF; Leonardi, Michael; Martinón-Torres, Federico; Miranda,Mariano; Perez Porcuna, Xavier Maria; Phongsamart, Wanatpreeya; Sharifah Huda, Engku Alwi; Toh, Teck-Hock; Twiggs, Jerry; Ulied Arminana, Angels; Varman, Meera; Zissman, Edward. GSK Vaccinesstaff: Caplanusi, Adrian; Carryn, Stephane; Henry, Ouzama; Povey, Michael.
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
MENINGOCOCCAL B VACCINE IMMUNOGENICITY IN CHILDREN WITH DEFECTS IN COMPLEMENT AND SPLENIC FUNCTION
Federico Martinón-Torres, Ewa Bernatowska, Anna Shcherbina, Susanna Esposito, Leszek Szenborn, Magda Campins Marti, Stephen Hughes, Saul N. Faust, Luis I. Gonzalez-Granado, Ly-Mee Yu, Diego D’Agostino, Marco Calabresi, Daniela Toneatto, Matthew D. Snape
Doi:
Pediatrics
Factor de impacto:
Q1
Doi:
MORTALITY AND MORBIDITY IN COMMUNITY-ACQUIRED SEPSIS IN EUROPEAN PEDIATRIC INTENSIVE CARE UNITS: A PROSPECTIVE COHORT STUDY FROM THE EUROPEAN CHILDHOOD LIFE-THREATENING INFECTIOUS DISEASE STUDY (EUCLIDS)
Navin P. Boeddha, Luregn J. Schlapbach, Gertjan J. Driessen, Jethro A. Herberg, Irene Rivero-Calle, Miriam Cebey-López, Daniela S. Klobassa, Ria Philipsen, Ronald de Groot, David P. Inwald, Simon Nadel, Stéphane Paulus, Eleanor Pinnock, Fatou Secka, Suzanne T. Anderson, Rachel S. Agbeko, Christoph Berger, Colin G. Fink, Enitan D. Carrol, Werner Zenz, Michael Levin, Michiel van der Flier, Federico Martinón-Torres, Jan A. Hazelzet, Marieke Emonts and on behalf of the EUCLIDS consortium
Doi:
Critical Care
Factor de impacto:
Q1
Doi:
A 2-TRANSCRIPT HOST CELL SIGNATURE DISTINGUISHES VIRAL FROM BACTERIAL DIARRHEA AND IT IS INFUENCED BY THE SEVERITY OF SYMPTOMS
R. Barral-Arca, J. Pardo-Seco, F. Martinón-Torres & A. Salas
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol.
Emily Bongard, Alike W van der Velden, Johanna Cook, Ben Saville, Philippe Beutels, Rune Munck Aabenhus, Curt Brugman, Slawomir Chlabicz, Samuel Coenen, Annelies Colliers, Melanie Davies, Muireann De Paor, An De Sutter, Nick A Francis, Dominik Glinz, Maciek Godycki-ćwirko, Herman Goossens, Jane Holmes, Margareta Ieven, Menno de Jong, Morten Lindbaek, Paul Little, Frederico Martinón-Torres, Ana Moragas, József Pauer, Markéta Pfeiferová, Ruta Radzeviciene-Jurgute, Pär-Daniel Sundvall, Antoni Torres, Pia Touboul, Dionyssios Varthalis, Theo Verheij, Christopher C Butler
Doi:
BMJ Open 2018
Factor de impacto:
Q2
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi: